Empagliflozin Versus Vildagliptin in CAD Patients With T2DM
Condition(s):Coronary Artery Disease; Type 2 DiabetesLast Updated:March 18, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Disease; Type 2 DiabetesLast Updated:March 18, 2024Recruiting
Condition(s):Diabetes Mellitus, Type 2; Sarcopenia; Weight Loss; FrailtyLast Updated:June 18, 2018Unknown status
Condition(s):End Stage Renal Disease on DialysisLast Updated:February 7, 2024Recruiting
Condition(s):Posttransplant Diabetes MellitusLast Updated:May 7, 2019Completed
Condition(s):Heart FailureLast Updated:December 26, 2023Recruiting
Condition(s):Kidney Transplant; Complications; Diabetes Mellitus, Type 2Last Updated:February 28, 2024Recruiting
Condition(s):Post-operative Atrial Fibrillation; CABGLast Updated:November 22, 2023Recruiting
Condition(s):CancerLast Updated:October 26, 2023Not yet recruiting
Condition(s):Cardiogenic ShockLast Updated:May 30, 2023Not yet recruiting
Condition(s):NephropathyLast Updated:July 30, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.